I 
10. References. 
1. Boat TF, Welsh M J , Beaudet AL. Cyscic Fibrosis. In: Scriver CR, Beaudet 
AL, Sly US , Valle, eds . The Metabolic Basis of Inherited Disease . New 
York: McGraw-Hill; 1989: 2649-2680. 
2. Tsui L-C, Buchwald M. Biochemical and molecular genetics of cystic fi- 
brosis. Adv Hum Genet 1991; 20: 153-266, 311-312. 
3. Welsh M J , Fick RB . Cystic fibrosis. J Clin Invest 1987; 80: 1523-1526. 
4. Starnes VA, Lewiston N, Theodore J, Stoehr C, Sinson E, Shumway NE, Oyer 
PE. Cystic fibrosis. J Thorac Cardiovasc Surg 1992; 103: 1008-1014. 
5. Elborn JS, Shale DJ . Cystic fibrosis. 2. Lung injury in cystic fibrosis. 
Thorax 1990; 45: 970-973. 
6. Bedrossian CWM, Greenberg SD, Singer DB, Hansen JJ, Rosenberg HS . The 
lung in cystic fibrosis: A quantitative study including prevalence of 
pathologic findings among different age groups. Hum Pathol 1976; 7 (2): 
195-204. 
7. Birrer P, McElvaney NG , Hubbard RC , Rudeberg A, Sommer CW, Leichti-Gal- 
lati S, Kraemer R, Crystal RG . Neutrophil elastase anti -neutrophil elas- 
tase imbalance on the respiratory epithelial surface of children with 
cystic fibrosis. Am Rev Respir Dis 1994; (in press). 
8. Kulczycki LL, Murphy TM, Bellanti JA. Pseudomonas colonization in cystic 
fibrosis: A study of 160 patients. JAMA 1978; 240: 30-34. 
9. Hubbard RC , McElvaney NG , Birrer P, Shak S, Robinson WW, Jolley C, Wu M, 
Chernick MS, Crystal RG. A preliminary study of aerosolized recombinant 
human deoxyribonuclease I in the treatment of cystic fibrosis. N Engl J 
Med 1992; 326: 812-815. 
10. Woods DE, Bass JA, Johanson WG,Jr.. Role of adherence in the pathogene- 
sis of Pseudomonas aeruginosa lung infection in cystic fibrosis pa- 
tients. Infect Immun 1980; 30: 694-699. 
11. McElvaney NG, Hubbard RC , Birrer P, Chernick MS, Caplan DB, Frank MM, 
Crystal RG. Aerosol alpha 1-antitrypsin treatment for cystic fibrosis. 
Lancet 1991; 337: 392-394. 
12. Doring G. Polymorphonuclear leukocyte elastase: its effect on the patho- 
genesis of Pseudomonas aeruginosa infection in cystic fibrosis. Antibiot 
Cheraother 1989; 42: 169-176. 
13. Roum JH, Buhl R, McElvaney NG , Borok Z, Chernick MM, Caplan D, Crystal 
RG. In vitro evaluation of the ability of glutathione to suppress the 
inflammatory cell derived oxidant burden in respiratory epithelial lin- 
ing fluid of individuals with cystic fibrosis. Clin Res 1990; 38 (2): 
440A (Abstract) . ' 
Recombinant DNA Research, Volume 20 
[215] 
